Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | R&D spending in billion U.S. dollars |
|---|---|
| 2024* | 38.9 |
| 2023* | 37.3 |
| 2022* | 35.8 |
| 2021* | 34.3 |
| 2020* | 32.8 |
| 2019* | 31.3 |
| 2018* | 30 |
| 2017 | 28.6 |
| 2016 | 27.4 |
| 2015 | 26 |
| 2014 | 25.6 |
| 2013 | 25 |
| 2012 | 24.1 |
| 2011 | 23.4 |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
September 2018
More information
Region
Worldwide
Survey time period
2011 to 2018
Supplementary notes
The statistic is based on the top 300 medtech companies. R&D spend in 2017 based on company reported data. Forecast medtech R&D spend based on a consensus of leading equity analysts’ estimates for company level R&D spend, extrapolated to medtech R&D when a company has non-medtech R&D activity. Medtech R&D is not disclosed by a number of companies, and this analysis is limited to those companies with sufficient disclosure.
* Forecast.
Citation formats
